ReviewHigh-Yield Study Guide with 150
Practice Questions, Answers, and Detailed
Rationales Complete A+ Guide for ANCC
Certification Success
SECTION 1: NEUROBIOLOGY AND NEUROTRANSMITTERS
QUESTION 1
Where is norepinephrine primarily produced in the brain?
A. Raphe nuclei
B. Substantia nigra
C. Locus coeruleus
D. Basal nucleus of Meynert
Answer: C. Locus coeruleus
Rationale: Norepinephrine is primarily synthesized in the locus
coeruleus located in the pons and medullary reticular formation. It
projects throughout the CNS and is associated with mood disorders,
attention, and arousal. Serotonin is produced in the raphe nuclei,
dopamine in the substantia nigra and ventral tegmental area, and
acetylcholine in the basal nucleus of Meynert .
,QUESTION 2
Which neurotransmitter is most closely associated with depression?
A. Dopamine
B. Norepinephrine
C. Serotonin
D. Acetylcholine
Answer: C. Serotonin
Rationale: Serotonin deficiency is strongly linked to depressive
symptoms. This forms the basis for the monoamine hypothesis of
depression. Many antidepressants, particularly SSRIs (selective
serotonin reuptake inhibitors), target serotonin reuptake to increase
synaptic availability .
QUESTION 3
Dopamine is synthesized in which areas of the brain?
A. Raphe nuclei
B. Locus coeruleus
C. Substantia nigra and ventral tegmental area
D. Basal forebrain
Answer: C. Substantia nigra and ventral tegmental area
Rationale: Dopamine-producing neurons are primarily located in the
substantia nigra (nigrostriatal pathway, involved in movement) and
the ventral tegmental area (mesolimbic and mesocortical pathways,
involved in reward, motivation, and psychosis). Dysregulation of
dopamine is implicated in addiction, schizophrenia, and Parkinson's
disease .
QUESTION 4
,The amygdala is primarily responsible for:
A. Memory formation
B. Emotional processing and fear responses
C. Executive function
D. Language comprehension
Answer: B. Emotional processing and fear responses
Rationale: The amygdala, a limbic system structure, is central to
processing emotions, particularly fear and anxiety. It evaluates the
emotional significance of stimuli and generates appropriate
behavioral responses. It is hyperactive in anxiety disorders and PTSD .
QUESTION 5
GABA is the primary __________ neurotransmitter in the brain.
A. Excitatory
B. Inhibitory
C. Modulatory
D. Neurotrophic
Answer: B. Inhibitory
Rationale: GABA (gamma-aminobutyric acid) is the most abundant
inhibitory neurotransmitter in the CNS. It reduces neuronal
excitability and is the target of benzodiazepines and barbiturates,
which enhance GABA's effects to produce sedation, anxiolysis, and
anticonvulsant effects. Low GABA activity is associated with anxiety
disorders .
QUESTION 6
Glutamate is the primary __________ neurotransmitter in the brain.
, A. Excitatory
B. Inhibitory
C. Modulatory
D. Neurotrophic
Answer: A. Excitatory
Rationale: Glutamate is the most abundant excitatory
neurotransmitter. It is involved in synaptic plasticity, learning, and
memory. Excessive glutamate activity can lead to excitotoxicity,
implicated in neurodegenerative disorders and stroke. Ketamine, an
NMDA receptor antagonist, produces rapid antidepressant effects by
modulating glutamate .
QUESTION 7
A patient on clozapine who smokes cigarettes may require:
A. Lower doses of clozapine
B. Higher doses of clozapine
C. No dose adjustment
D. Discontinuation of clozapine
Answer: B. Higher doses of clozapine
Rationale: Smoking induces the cytochrome P450 enzyme CYP1A2,
which is responsible for metabolizing clozapine. Induction increases
metabolism, leading to decreased serum levels of clozapine. Smokers
typically require higher doses to achieve therapeutic levels. If the
patient stops smoking, levels may rise, requiring dose reduction to
prevent toxicity .
QUESTION 8